Algonomics home

Profile and Mission

Algonomics' vision is to become the leading global provider of integrated immunogenicity services for the development of safe and effective biotherapeutics.

We intend to do this by making your success … our mission!

Our mission is accomplished by providing you - and the biopharma industry - with the best tools and most comprehensive solutions to manage the immunogenicity of your drug leads. We thereby minimize the risk of adverse effects and maximize drug efficacy.

Profile

Since its founding in 1999, Algonomics has arguably become one of the world's leading providers of integrated immunogenicity services for the biopharmaceutical industry. Our steady growth not only reflects Algonomics' successful track record, but our continuing determination to offer the best tools and most comprehensive solutions for optimizing the safety and immunogenicity of biotherapeutic drug leads.

Algonomics has achieved its reputation for excellence by applying a broad and expanding repertoire of state-of-the-art platforms and services that span the entire non-clinical drug development roadmap: from early lead selection/optimization to the very doorstep of Phase I. These award-winning tools include:

  • Epibase® — the patented in silico T cell epitope bioinformatics tool of choice by protein engineers and drug developers for immunogenicity assessment
  • Epibase-IV — the widely used in vitro cellular assay platform that screens and validates the safety and immunogenicity of protein therapeutics or vaccine candidates
  • Tripole® — the smart, proprietary toolbox for refined downstream antibody/protein modeling and structural analysis

In the hands of Algonomics' experienced scientists, these platforms can be synergistically combined to maximize the rational design of best-in-class therapeutic proteins and vaccines. The Algonomics approach also translates into time- and cost-savings, and into added confidence for drug developers through documented risk-management planning for regulatory submissions.

Drug development is evolving rapidly... So evolve with it!
Let's discuss how you can harness Algonomics' pacesetting services to help you achieve your goals.